|
Symbol
|
RMA93V | RMBA5V | CCCBKB | RMALEV | RMAQ2V | OYCRCH | RMBM5V | ABWMSQ | PDLRCH | PCJRCH | CIEBKB | RMA54V | PEZRCH | CISBKB | Z0AASZ | RMADDV | PNARCH | KZNEDU | KZKXDU | KZUQDU |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Barrier Reverse Convertible | Worst of Reverse Convertible | Worst of Reverse Convertible | Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible |
|
Underlying
|
Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Alcon / Lonza Group N / Novartis AG / Roche PS | Lonza Group N / Sandoz Group AG / Siegfried Hldg. AG / Straumann Hldg. AG | Lonza Group N / Novartis AG / Roche PS / Straumann Hldg. AG | Holcim/Amrize Basket / Lonza Group N / Partners Group Hldg. AG / Sonova Hldg. AG | Lonza Group N / Nestlé S.A. / Novartis AG / Roche PS / Straumann Hldg. AG | Clariant AG / Lonza Group N / Sandoz Group AG | Ems-Chemie Hldg. AG / Lonza Group N / Sonova Hldg. AG | Geberit AG / Holcim/Amrize Basket / Lonza Group N / Sika AG | Alcon / Lonza Group N / Novartis AG / Sandoz Group AG | Lonza Group N / Sandoz Group AG / Straumann Hldg. AG | Alcon / Givaudan / Lonza Group N / Sandoz Group AG | BKW AG / Kühne & Nagel Intl. AG / Lonza Group N | Lonza Group N / Sandoz Group AG / Straumann Hldg. AG | Galderma Group AG / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Lonza Group N / Sandoz Group AG / Sonova Hldg. AG | Lonza Group N / Partners Group Hldg. AG / Swiss RE AG | ABB N / Givaudan / Lonza Group N | Lonza Group N / Nestlé S.A. / Novartis AG / Roche PS |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
12.01.2027 | 05.01.2027 | 09.02.2027 | 15.03.2027 | 19.04.2027 | 01.04.2027 | 11.10.2027 | 30.10.2026 | 04.11.2026 | 28.10.2026 | 18.11.2026 | 02.11.2026 | 18.11.2026 | 25.08.2027 | 11.11.2026 | 05.01.2027 | 27.10.2026 | 05.02.2027 | 15.01.2027 | 12.02.2027 |
| Bid | 99.81 | 99.01 | 99.56 | 68.80 | 93.12 | 88.75 | 89.43 | 83.54 | 92.24 | - | 101.33 | 99.30 | 100.66 | 96.88 | - | 100.30 | - | 47.900 | 100.90 | 99.65 |
| Ask | 101.21 | 100.41 | 100.36 | - | 94.49 | 89.55 | 90.79 | - | - | - | 102.14 | 100.30 | - | 97.68 | - | 101.71 | - | 48.900 | 101.90 | 100.60 |